Selected 2001 Venture Capital Transactions as Company Counsel

Selected 2001 Venture Capital Transactions as Company Counsel

Publication

In 2001, we served as company counsel in more than 150 venture financings raising more than $3 billion. The following are selected highlights from our 2001 transactions:

  • Achillion Pharmaceuticals — $41 million
  • Aegis Semiconductor — $16.2 million
  • Airvana — $29.5 million
  • Aplion Networks — $30 million
  • Ardais — $36 million
  • Business Layers — $25 million
  • Cerylion — $5.1 million
  • ChannelWave Software — $29 million
  • CoreChange — $36 million
  • deNovis — $43.8 million
  • Digital 5 — $12 million
  • Ellacoya Networks — $25 million
  • EM4 Photonics — $$16 million
  • Encompys — $50 million
  • Endeca Technologies — $15 million
  • First Genetic Trust — $14.3 million
  • Globalware Solutions — $30 million
  • GoldK — $36.8 million
  • InfiniSwitch—$26 million
  • Infinity Pharmaceuticals — $12.2 million
  • InteQ — $57 million
  • Nantero — $6 million
  • netDecide — $9.2 million
  • NitroMed — $31.4 million
  • Novirio Pharmaceuticals — $44 million
  • PharMetrics — $11 million
  • PhotonEx — $90 million
  • Polychromix — $7.1 million
  • Princeton eCom — $35.5 million
  • Quallaby — $14.5 million
  • Sandgate Systems — $10 million
  • Starent Networks — $22 million
  • Storability — $30 million
  • TargetRx — $10 million
  • Telica — $60 million
  • Torrent Systems — $12 million
  • TruSecure — $22 million
  • Village Ventures — $50.9 million
  • VistaPrint.com — $12.3 million
  • WaterCove Networks — $40 million
  • Winphoria Networks — $42 million
  • yet2.com — $20 million

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.